Carlos Arteaga
MD
Professor and Director
👥Biography 个人简介
Carlos Arteaga is one of the foremost experts on endocrine therapy resistance mechanisms in breast cancer, with particular focus on HER2-ER crosstalk as a driver of treatment failure. His landmark studies demonstrated that HER2 signaling activates ER in a ligand-independent manner contributing to tamoxifen and aromatase inhibitor resistance. He has investigated PI3K pathway inhibitors combined with endocrine therapy for resistant disease. His research has directly shaped clinical trials and treatment guidelines for HR+/HER2+ breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Carlos Arteaga 的研究动态
Follow Carlos Arteaga's research updates
留下邮箱，当我们发布与 Carlos Arteaga（UT Southwestern Harold C. Simmons Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment